Georgetown

Washington D.C., District of Columbia 20057

0 studies enrolling now · 5 studies all time

What they study most

Bladder Cancer, Colorectal Cancer (CRC), Gastric Cancer, Glioblastoma, Glioblastoma Multiforme, HIV Associated Lymphoma, Head and Neck Cancer, Lung Cancer, Melanoma, Mesothelioma, Metastatic Cancer, Metastatic HER2 Positive Gastroesophageal Junction Cancer

Studies at this site

• HIV Antigen-specific T-cells Targeting Conserved Epitopes (HST-NEETs) BMTCTN1903 — Completed
• Arginase Inhibitor INCB001158 as a Single Agent and in Combination With Immune Checkpoint Therapy in Patients With Advanced/Metastatic Solid Tumors — Completed
• Clinical Study of CMP-001 in Combination With Pembrolizumab or as a Monotherapy — Completed
• CYNK-101 in Combination with Trastuzumab and Pembrolizumab in Patients with Locally Advanced Unresectable or Metastatic HER2-Positive Gastric or Gastroesophageal Junction (G/GEJ) Adenocarcinoma — Stopped early
• MBM-02 (Tempol) for the Treatment of Glioblastoma Multiforme (GBM) — Status unconfirmed